pharma news

News

Homeless man on ground beside subway entrance

PHTI delivers its verdict on DHTs for opioid use disorder

Digital health tech for opioid use disorder can be as effective as regular care, but it doesn't expand access and may increase the cost of care.

News

As Trump visits UK, GSK pledges $30bn in US investment

GSK's investment drive includes a new facility in Pennsylvania, and follows some high-profile abandoned projects by drugmakers in the UK.

News

AZ's bid for Fasenra approval in COPD falls short

AstraZeneca has abandoned Fasenra development in COPD, but there is better news for the company with a new version of lupus drug Saphnelo.

News

Flood of warning letters follows DTC ad clampdown

The FDA has lost no time following through on its plan to tighten up DTC advertising of medicines, sending out dozens of untitled and warning letters.

News

Imfinzi becomes first NHS drug for aggressive lung cancer

AstraZeneca's PD-L1 inhibitor Imfinzi is the first drug therapy to be recommended for routine NHS use in limited-stage small cell lung cancer.

News

FDA's Makary explains 'overdue' pharma ads crackdown

FDA Commissioner Marty Makary has called DTC ads for medicines a "public health crisis" as the industry prepares for a regulatory crackdown.

PHTI delivers its verdict on DHTs for opioid use disorder

As Trump visits UK, GSK pledges $30bn in US investment

AZ's bid for Fasenra approval in COPD falls short

Flood of warning letters follows DTC ad clampdown

Imfinzi becomes first NHS drug for aggressive lung cancer

FDA's Makary explains 'overdue' pharma ads crackdown

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

pharma news

Editor's Picks